Literature DB >> 18330633

Resistance to simulated gastrointestinal conditions and adhesion to mucus as probiotic criteria for Bifidobacterium longum strains.

E Izquierdo1, M Medina, S Ennahar, E Marchioni, Y Sanz.   

Abstract

Eight Bifidobacterium longum strains, including reported probiotic strains (commercial and noncommercial), collection strains, and laboratory isolates, were investigated for their ability to adhere to mucin as well as their ability to tolerate acid and bile. Strains could be discriminated based on their sensitivity at pH values of 2.0 to 2.5 and bile concentrations of 0.5% to 2.0%. B. longum NCC 2705, a strain known for its probiotic properties, showed the highest resistance to gastrointestinal conditions, whereas the commercial probiotic strains B. longum BB 536 and SP 07/3 were the least resistant. In parallel, the human isolate B. longum BIF 53 showed the highest adhesion to mucin, whereas the commercial probiotic strains B. longum W 11, BB 536, and SP 07/3 were the least adhesive. The bacterial adhesion to mucin of strains B. longum NCC 2705 and BIF 53 could be reduced by lysozyme, indicating that cell-wall components are involved in the adhesion process. These results showed that there is no obvious link between adhesion and resistance to gastrointestinal conditions and the probiotic status of the studied strains. This calls for a definition of conditions for in vitro tests that better predict the in vivo functionality of probiotic strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18330633     DOI: 10.1007/s00284-008-9135-7

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  10 in total

Review 1.  Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens.

Authors:  Alain L Servin; Marie-Hélène Coconnier
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-10       Impact factor: 3.043

2.  Comparison of four methods to enumerate probiotic bifidobacteria in a fermented food product.

Authors:  Sampo J Lahtinen; Miguel Gueimonde; Arthur C Ouwehand; Johanna P Reinikainen; Seppo J Salminen
Journal:  Food Microbiol       Date:  2005-10-26       Impact factor: 5.516

3.  Production of bacteriocin-like inhibitory compounds by human fecal Bifidobacterium strains.

Authors:  M Carmen Collado; Manuel Hernández; Yolanda Sanz
Journal:  J Food Prot       Date:  2005-05       Impact factor: 2.077

4.  Probiotic bacteria: legislative framework-- requirements to evidence basis.

Authors:  Maya Pineiro; Catherine Stanton
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

Review 5.  Probiotics: facts and myths.

Authors:  A C Senok; A Y Ismaeel; G A Botta
Journal:  Clin Microbiol Infect       Date:  2005-12       Impact factor: 8.067

6.  Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus.

Authors:  Patricia Ruas-Madiedo; Miguel Gueimonde; Abelardo Margolles; Clara G de los Reyes-Gavilán; Seppo Salminen
Journal:  J Food Prot       Date:  2006-08       Impact factor: 2.077

7.  Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion.

Authors:  M Carmen Collado; Miguel Gueimonde; Manuel Hernández; Yolanda Sanz; Seppo Salminen
Journal:  J Food Prot       Date:  2005-12       Impact factor: 2.077

8.  The ability of probiotic bacteria to bind to human intestinal mucus.

Authors:  P V Kirjavainen; A C Ouwehand; E Isolauri; S J Salminen
Journal:  FEMS Microbiol Lett       Date:  1998-10-15       Impact factor: 2.742

9.  A fluorescence-based method for the detection of adhesive properties of lactic acid bacteria to Caco-2 cells.

Authors:  M A Bianchi; D Del Rio; N Pellegrini; G Sansebastiano; E Neviani; F Brighenti
Journal:  Lett Appl Microbiol       Date:  2004       Impact factor: 2.858

10.  Binding of Bifidobacterium bifidum and Lactobacillus reuteri to the carbohydrate moieties of intestinal glycolipids recognized by peanut agglutinin.

Authors:  Takao Mukai; Shigenobu Kaneko; Mitsuyo Matsumoto; Hitoshi Ohori
Journal:  Int J Food Microbiol       Date:  2004-02-01       Impact factor: 5.277

  10 in total
  18 in total

1.  Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections.

Authors:  José Antonio Moreno Muñoz; Empar Chenoll; Beatriz Casinos; Esther Bataller; Daniel Ramón; Salvador Genovés; Rebeca Montava; Juan Manuel Ribes; Javier Buesa; Joan Fàbrega; Montserrat Rivero
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

2.  Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori.

Authors:  E Chenoll; B Casinos; E Bataller; P Astals; J Echevarría; J R Iglesias; P Balbarie; D Ramón; S Genovés
Journal:  Appl Environ Microbiol       Date:  2010-12-17       Impact factor: 4.792

3.  Comparative proteomic analysis of Lactobacillus plantarum for the identification of key proteins in bile tolerance.

Authors:  Erwann Hamon; Peter Horvatovich; Esther Izquierdo; Françoise Bringel; Eric Marchioni; Dalal Aoudé-Werner; Saïd Ennahar
Journal:  BMC Microbiol       Date:  2011-03-29       Impact factor: 3.605

4.  Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats.

Authors:  Jana Cinova; Giada De Palma; Renata Stepankova; Olga Kofronova; Miloslav Kverka; Yolanda Sanz; Ludmila Tuckova
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

5.  Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Eleonora Scorletti; Paul R Afolabi; Elizabeth A Miles; Debbie E Smith; Amal Almehmadi; Albandri Alshathry; Caroline E Childs; Stefania Del Fabbro; Josh Bilson; Helen E Moyses; Geraldine F Clough; Jaswinder K Sethi; Janisha Patel; Mark Wright; David J Breen; Charles Peebles; Angela Darekar; Richard Aspinall; Andrew J Fowell; Joanna K Dowman; Valerio Nobili; Giovanni Targher; Nathalie M Delzenne; Laure B Bindels; Philip C Calder; Christopher D Byrne
Journal:  Gastroenterology       Date:  2020-01-25       Impact factor: 33.883

6.  Lactobacillus fermentum ATCC 23271 Displays In vitro Inhibitory Activities against Candida spp.

Authors:  Monique S do Carmo; Francisca M F Noronha; Mariana O Arruda; Ênnio P da Silva Costa; Maria R Q Bomfim; Andrea S Monteiro; Thiago A F Ferro; Elizabeth S Fernandes; Jorge A Girón; Valério Monteiro-Neto
Journal:  Front Microbiol       Date:  2016-10-27       Impact factor: 5.640

7.  Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients.

Authors:  Marcela Medina; Giada De Palma; Carmen Ribes-Koninckx; Miguel Calabuig; Yolanda Sanz
Journal:  J Inflamm (Lond)       Date:  2008-11-03       Impact factor: 4.981

8.  Probiotic encapsulation technology: from microencapsulation to release into the gut.

Authors:  Gildas K Gbassi; Thierry Vandamme
Journal:  Pharmaceutics       Date:  2012-02-06       Impact factor: 6.321

9.  Effects of milk components and food additives on survival of three bifidobacteria strains in fermented milk under simulated gastrointestinal tract conditions.

Authors:  Małgorzata Ziarno; Dorota Zaręba
Journal:  Microb Ecol Health Dis       Date:  2015-11-04

10.  High Iron-Sequestrating Bifidobacteria Inhibit Enteropathogen Growth and Adhesion to Intestinal Epithelial Cells In vitro.

Authors:  Pamela Vazquez-Gutierrez; Tomas de Wouters; Julia Werder; Christophe Chassard; Christophe Lacroix
Journal:  Front Microbiol       Date:  2016-09-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.